Status:
RECRUITING
Analysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment
Lead Sponsor:
University Medical Center Groningen
Conditions:
Emphysema
Eligibility:
All Genders
Brief Summary
Rationale: Chronic obstructive pulmonary disease (COPD) is characterised by a high prevalence of peripheral muscle dysfunction, which can have significant clinical consequences, including decreased ex...
Eligibility Criteria
Inclusion
- Patient is scheduled for a bronchoscopic lung volume treatment using one-way endobronchial valves;
- Patient read, understood and signed the Informed Consent Form.
Exclusion
- Inability to perform a cycle ergometry test;
- Contraindications for undergoing a magnetic resonance imaging scan (e.g. claustrophobia, implanted cardiac devices);
- Body length \>190cm;
- Any anticoagulant therapy;
- COPD exacerbation 4 weeks prior to testing.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06025500
Start Date
October 1 2024
End Date
December 1 2025
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy Medical Center Groningen
Groningen, Netherlands